Compared with the NC group (0.9% saline solution), subcutaneous tumor growth was significantly suppressed in both the sh-AURKA group and the combination treatment group (sh-AURKA+ AS/BJO-NE group), with a more pronounced inhibitory effect observed in the combination group (Figure 9A–C). This evidence concerns the gene AURKA and neoplasm.